Dublin, Nov. 01, 2018 (GLOBE NEWSWIRE) -- The "Global Chronic Myeloid Leukemia Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering.

Global Chronic Myeloid Leukemia Market and Competitive Landscape - 2018, provides comprehensive insights into Chronic Myeloid Leukemia pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Chronic Myeloid Leukemia market size and drug sales. This research also provides insights into Chronic Myeloid Leukemia epidemiology and late stage pipeline.

The research is classified into following sections - Chronic Myeloid Leukemia overview with definitions, symptoms, etiology, diagnosis, treatment options; Chronic Myeloid Leukemia pipeline insights covering late stage clinical trials pipeline; Chronic Myeloid Leukemia prevalence trends by countries; Chronic Myeloid Leukemia market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries - US, Germany, France, Italy, Spain, UK, Japan.

Research Scope:

• Chronic Myeloid Leukemia pipeline: Find out the drugs in clinical trials for Chronic Myeloid Leukemia by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
• Chronic Myeloid Leukemia epidemiology: Find out the prevalence of Chronic Myeloid Leukemia by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2023
• Chronic Myeloid Leukemia products: Identify key products marketed and prescribed for Chronic Myeloid Leukemia by brand name, by molecule, by company, by branded / generic, by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
• Chronic Myeloid Leukemia market size: Find out the market size for Chronic Myeloid Leukemia drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2014
• Chronic Myeloid Leukemia drug sales: Find out the sales of Chronic Myeloid Leukemia drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
• Chronic Myeloid Leukemia drugs sales forecast: Sales forecast for Chronic Myeloid Leukemia drugs to 2023 by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
• Chronic Myeloid Leukemia market share analysis: Find out the market shares of Chronic Myeloid Leukemia drugs and outlook by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan

Benefits of this Research:

• Evaluate commercial market opportunities for Chronic Myeloid Leukemia drugs
• Synthesize insights for business development & licensing
• Track market size, competitor drug sales, market shares in Chronic Myeloid Leukemia market
• Develop in-depth knowledge of competition and markets
• Analyze sales data to update your brand planning trackers
• Develop tactics and strategies to take advantage of opportunities in the market
• Track market trends and analyze key events in Chronic Myeloid Leukemia market
• Develop forecast models, healthcare frameworks, or economic models
• Answer key business questions; supports decision making in R&D to long term marketing strategies

Key Topics Covered:

1. Chronic Myeloid Leukemia: Disease Overview

2. Chronic Myeloid Leukemia Pipeline Insights

3. Chronic Myeloid Leukemia Epidemiology Analysis

4. US Chronic Myeloid Leukemia Market Insights

5. Germany Chronic Myeloid Leukemia Market Insights

6. France Chronic Myeloid Leukemia Market Insights

7. Italy Chronic Myeloid Leukemia Market Insights

8. Spain Chronic Myeloid Leukemia Market Insights

9. UK Chronic Myeloid Leukemia Market Insights

10. Europe Chronic Myeloid Leukemia Market Insights

11. Japan Chronic Myeloid Leukemia Market Insights

12. Global Chronic Myeloid Leukemia Market Insights

13. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/gsshp8/global_chronic?w=12

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Leukemia Drugs